DP044 | PRELIMINARY ANALYSIS OF CLL-ZANU2024, AN ITALIAN NON-INTERVENTIONAL STUDY ASSESSING THE REAL-WORLD USE OF ZANUBRUTINIB IN THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
The CLL-ZANU2024 study is an Italian, observational, multicenter, longitudinal secondary data analysis evaluating the safety and efficacy of Zanubrutinib in real-world post-marketing setting. It retrospectively examines chronic lymphocytic leukemia (CLL) patients who initiated Zanubrutinib from Oct...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ferrata Storti Foundation
2025-09-01
|
| Col·lecció: | Haematologica |
| Accés en línia: | https://haematologica.org/article/view/12648 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
